Lanean...
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
More than 40 monoclonal antibodies (mAbs) have been approved for a number of disease indications with only one of these (Synagis) — for a viral disease, and not for therapy but for prevention. However, in the last decade novel potent mAbs have been discovered and characterized with potential as ther...
Gorde:
| Argitaratua izan da: | Virol Sin |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SP Wuhan Institute of Virology, CAS
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7090799/ https://ncbi.nlm.nih.gov/pubmed/23575729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12250-013-3313-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|